Kerala Ayurveda Limited

BSE: KERALAYUR530163ISIN INE817B01025

Healthcare
Pharmaceuticals

Share price

₹144.35+7.05 (+5.13%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹416.00
52W low: ₹130.00
Off 52W high: -65.30%
1M return: -1.57%
3M return: -7.91%
6M return: -32.07%
1Y return: -64.02%
20D avg volume: 9,119
50 DMA: ₹158.53
200 DMA: ₹192.34

Key ratios Consolidated

Market cap: ₹187.58 Cr
Current price: ₹144.35
52W high / low: ₹416.00 / ₹130.00
Face value: ₹10.00
P/E: -7.46
P/B: —
EPS (TTM): ₹-19.35
Book value / share: —
ROE: —
ROCE: -23.10%
Operating margin: —
Net margin: —
Debt / equity: 5.43
Net debt: ₹75.08 Cr
Interest cover: -1.23
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 53.3 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	33.19	34.74	32.96	34.84	28.61	31.32	31.13	31.85	27.47	—
	0.26	1.91	1.13	1.70	9.47	0.73	0.23	0.64	0.22	—
	33.45	36.64	34.09	36.54	38.08	32.05	31.36	32.49	27.69	—
	41.69	44.62	38.46	43.36	35.27	45.86	33.46	29.01	27.49	—
	7.35	7.33	2.52	10.51	5.62	5.90	5.35	4.67	4.59	—
	0.40	0.51	0.32	0.66	0.45	3.65	0.59	1.05	—	—
	18.84	19.54	15.63	15.84	14.96	19.34	13.11	11.86	9.76	—
	2.79	1.10	2.84	2.58	0.82	2.48	0.43	0.72	0.46	—
	1.87	1.69	1.15	0.99	1.66	1.92	0.72	1.98	0.36	—
	14.00	14.44	14.57	13.83	10.87	16.54	13.62	8.94	10.91	—
	-8.23	-7.98	-4.37	-6.82	2.81	-13.81	-2.11	3.48	0.21	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	-8.23	-7.98	-4.37	-6.82	2.81	-13.81	-2.11	3.48	0.21	—
	-0.15	0.59	0.23	-0.46	0.78	1.56	0.59	0.17	0.25	—
	-8.08	-7.40	-4.60	-6.34	2.03	-15.54	-2.70	3.65	0.46	—
	-6.24	-5.83	-3.69	-7.23	1.92	-13.68	-2.40	3.10	0.33	—
Key metrics
	-3.57	-5.19	-0.38	-3.25	5.29	-9.41	-0.96	6.18	1.03	—
	-10.80%	-14.90%	-1.20%	-9.30%	18.50%	-30.00%	-3.10%	19.40%	3.70%	—
	-24.30%	-21.30%	-14.00%	-18.20%	7.10%	-49.60%	-8.70%	11.50%	1.70%	—
	—	-17.60%	—	-13.30%	—	-27.80%	—	—	—	—
	16.00%	10.90%	5.90%	9.40%	4.10%	—	—	—	—	—
	-498.00%	52.40%	-70.40%	-273.70%	341.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	135.73	131.15	120.33	—
	5.00	14.21	1.82	—
	140.72	145.36	122.15	—
	168.13	161.72	134.39	—
	27.71	24.36	19.36	—
	1.89	1.94	3.64	—
	69.85	67.05	54.27	—
	9.31	7.34	4.09	—
	5.70	5.49	4.97	—
	56.84	54.26	48.36	—
	-27.40	-16.36	-12.24	—
	0.00	0.00	0.00	—
	-27.40	-16.36	-12.24	—
	0.21	0.04	1.72	—
	-26.42	-16.32	-14.70	—
	-22.99	-13.53	-12.79	—
Key metrics
	-12.39	-3.53	-3.18	—
	-9.13%	-2.70%	-2.60%	—
	-19.47%	-12.40%	-12.20%	—
	—	-23.10%	-20.00%	—
	10.43%	9.00%	—	—
	—	-11.00%	—	—
	—	-29.75	-8.50	—
	—	1.48	-0.33	—
	—	5.43	5.12	—
	—	75.08	62.58	—
	—	53.3	80.2	—
Balance sheet
	—	138.42	128.76	—
	—	44.81	40.67	—
	—	5.75	3.39	—
	—	13.81	19.30	—
	—	15.11	12.96	—
	—	7.85	4.82	—
	—	32.92	31.05	—
	—	9.77	5.79	—
	—	99.42	87.97	—
	—	80.83	65.97	—
	—	66.27	48.11	—
	—	14.56	17.86	—
	—	14.89	12.89	—
Cash flow
	—	-24.13	4.83	—
	—	-5.48	-14.77	—
	—	32.39	-9.48	—
	—	5.62	13.33	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	22.53	24.57	22.07	21.29	17.57	19.35	19.35	20.03	15.40	—
	1.28	4.70	0.98	2.26	10.00	4.38	0.13	0.39	0.28	—
	23.81	29.27	23.04	23.55	27.57	23.72	19.48	20.42	15.67	—
	31.84	38.27	26.69	29.42	24.99	34.60	19.65	21.14	17.40	—
	7.16	8.21	3.28	5.73	4.43	5.69	5.15	4.49	3.92	—
	0.35	0.27	0.08	0.45	0.25	0.78	0.51	0.99	—	—
	13.18	16.11	9.72	11.02	9.82	14.52	7.69	7.42	5.33	—
	2.81	1.97	1.98	2.54	0.77	2.81	0.38	0.33	0.40	—
	1.41	1.24	0.58	0.55	1.23	1.46	0.28	0.22	0.19	—
	8.25	10.48	9.63	10.17	7.60	10.53	5.97	—	6.13	—
	-8.03	-9.00	-3.65	-5.87	2.58	-10.88	-0.16	-0.71	-1.73	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	—	—
	-8.03	-9.00	-3.65	-5.87	2.58	-10.88	-0.16	-0.71	-1.73	—
	-0.36	1.07	-0.18	-0.47	0.51	0.98	0.08	0.17	0.43	—
	-7.67	-7.93	-3.47	-5.40	2.07	-11.86	-0.08	-0.54	-1.29	—
	-5.92	-6.25	-3.03	-4.58	1.73	-98.60	-0.07	-0.38	-1.01	—
Key metrics
	-3.81	-5.79	-1.09	-2.78	4.58	-6.61	0.50	-0.16	-1.14	—
	-16.90%	-23.60%	-4.90%	-13.10%	26.10%	-34.20%	2.60%	-0.80%	-7.40%	—
	-34.00%	-32.30%	-15.70%	-25.40%	11.80%	-61.30%	-0.40%	-2.70%	-8.40%	—
	—	-15.00%	—	-9.60%	—	-21.50%	—	—	—	—
	28.20%	27.00%	14.10%	6.30%	14.10%	—	—	—	—	—
	-470.50%	33.10%	-4,237.50%	-900.00%	260.50%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	90.46	85.48	72.69	—
	9.22	17.93	5.17	—
	99.67	103.42	77.86	—
	126.22	119.37	91.34	—
	24.38	21.66	18.58	—
	1.15	1.05	2.95	—
	50.03	46.67	35.52	—
	9.30	7.27	3.92	—
	3.78	3.60	2.15	—
	38.53	37.88	28.52	—
	-26.55	-15.95	-13.48	—
	0.00	0.00	0.00	—
	-26.55	-15.95	-13.48	—
	0.06	1.21	0.30	—
	-24.47	-14.74	-13.78	—
	-19.78	-12.21	-114.52	—
Key metrics
	-13.47	-5.08	-7.41	—
	-14.89%	-5.90%	-10.20%	—
	-27.05%	-17.20%	-19.00%	—
	—	-18.50%	-25.40%	—
	18.56%	17.60%	—	—
	—	-7.00%	—	—
	—	-28.25	-4.54	—
	—	1.70	-0.17	—
	—	1.94	2.15	—
	—	68.69	53.75	—
	—	139.5	141.2	—
Balance sheet
	—	139.66	118.89	—
	—	86.61	70.17	—
	—	1.57	0.36	—
	—	31.88	23.14	—
	—	9.56	10.22	—
	—	5.33	6.16	—
	—	26.38	23.48	—
	—	8.77	5.23	—
	—	92.81	81.31	—
	—	70.26	54.11	—
	—	66.26	48.11	—
	—	4.00	6.00	—
	—	36.15	25.13	—
Cash flow
	—	-25.05	2.28	—
	—	-3.19	-6.48	—
	—	29.86	-11.93	—
	—	3.20	6.82	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +18.56%
Profit YoY (TTM): -135.06%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +10.43%
Profit YoY (TTM): -110.35%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 21 Oct 2026

Promoter holding: 38.69%

Quarter	21 Oct 2026	September 2026	June 2026
Promoter %	38.69%	38.69%	35.60%

Holder	Type	Holding	Previous	Change
KATRA HOLDINGS LTD	Promoter	29.28%	29.28%	0.00%
KATRA HOLDING PRIVATE LIMITED	Promoter Group	9.41%	9.41%	0.00%
PORINJU VELIYATH	Public	3.06%	3.06%	0.00%
SANJIV DHIRESHBHAI SHAH	Public	2.39%	2.39%	0.00%
AUTHUM INVESTMENT AND INFRASTRUCTURE LIMITED	Public	1.73%	1.73%	0.00%
SURESH BHATIA HUF	Public	1.68%	1.68%	0.00%
DHEERAJ KUMAR LOHIA	Public	1.65%	1.65%	0.00%
AAMARA CAPITAL PRIVATE LIMITED	Public	1.26%	1.26%	0.00%
BHARAT TAPARIA	Public	1.25%	1.25%	0.00%
JAMISH INVESTMENT PVT. LTD.	Public	1.25%	1.25%	0.00%
ANIL KUMAR K	Public	1.23%	1.23%	0.00%
UTSAV RASIKLAL KAPADIA	Public	1.16%	1.16%	0.00%
SREERANGAM KUNJUPANICKER ARUNKUMAR	Public	1.12%	1.12%	0.00%
SANGEETHA ARUNKUMAR	Public	1.12%	1.12%	0.00%
PRADEEPKUMAR GHISULAL RATHOD HUF	Public	1.10%	1.10%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Kerala Ayurveda Limited	188	144.35	-7.46	-23.10%	+10.43% TTM	-110.35% TTM	-64.02%

Filings & corporate actions

Recent announcements

Announcement under Regulation 30(LODR) - Allotment21 Oct 2026 · Company Update / Allotment of Equity Shares
Compliances-Certificate under Reg-74(5) of SEBI (DP) Regulations,20185 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Shareholders meeting - Scrutinizer''s Report29 Sep 2026 · AGM/EGM / AGM
AGM Proceedings.28 Sep 2026 · Company Update / General
AGM Proceedings28 Sep 2026 · AGM/EGM / AGM
Closure of Trading Window28 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
News paper publication23 Sep 2026 · Company Update / Newspaper Publication
Corrigendum to the AGM Notice22 Sep 2026 · AGM/EGM / AGM
Intimation for Corrigendum to the notice of 34th AGM of Kerala Ayurveda Limited with respect to Preferential Issue.22 Sep 2026 · Company Update / Preferential Issue
Advertisement post-dispatch of Annual Report6 Sep 2026 · Company Update / Newspaper Publication
Notice of the 34th Annual General Meeting of the Company5 Sep 2026 · AGM/EGM / AGM
Annual Report of Kerala Ayurveda Limited for FY 2025-26.5 Sep 2026 · Others / Reg. 34 (1) Annual Report
News paper publication4 Sep 2026 · Company Update / Newspaper Publication
The Board of Directors of Kerala Ayurveda Limited approved Preferential Issue of Equity shares subject to the approval of the shareholders.4 Sep 2026 · Company Update / Preferential Issue
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/09/2026 ,inter alia, to consider and approve Inter alia to Consider and ....1 Sep 2026 · Board Meeting / Board Meeting
Announcement under Regulation 30 (LODR)-Newspaper Publication13 Aug 2026 · Company Update / Newspaper Publication
Announcement under Regulation 30 (LODR)- Scheme of Arrangement12 Aug 2026 · Company Update / Scheme of Arrangement
Announcement under Regulation 30(LODR)- Press Release12 Aug 2026 · Company Update / Press Release / Media Release
Announcement under Regulation 30 (LODR) - Allotment of ESOP12 Aug 2026 · Company Update / Allotment of ESOP / ESPS
Results - Financial Results for the Quarter ended 30th June 202612 Aug 2026 · Result / Financial Results
Outcome of Board 12th August 202612 Aug 2026 · Board Meeting / Outcome of Board Meeting
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the unaudited financial results ....6 Aug 2026 · Board Meeting / Board Meeting
Certificate under Reg.74(5) of SEBI (DP) Regulations 20183 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
closure of trading window25 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
News paper publication24 Jun 2026 · Company Update / Newspaper Publication
Revised Corporate announcement Pursuant to the query raised from BSE10 Jun 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Resignation of Independent Director9 Jun 2026 · Company Update / Change in Management
Intimation under regulation 30(5)9 Jun 2026 · Company Update / General
Appointment of Company secretary and Compliance officer9 Jun 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Appointment of New Company Secretary9 Jun 2026 · Company Update / Change in Management
ASCR 202630 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Newspaper publication - Financial Results27 May 2026 · Company Update / Newspaper Publication
Press Release25 May 2026 · Company Update / Press Release / Media Release
Appointment of Internal Auditor and Cost Auditor25 May 2026 · Company Update / Change in Management
Financial Results for the Year Ended 31st March 202625 May 2026 · Result / Financial Results
Outcome of Board meeting held on 25th May 202625 May 2026 · Board Meeting / Outcome of Board Meeting
Kerala Ayurveda Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve Board meeting on 25th May 202620 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....27 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Announcement Under Regulation 30 (LODR)16 Apr 2026 · Company Update / General
Clarification on Price Movement8 Apr 2026 · Company Update / General

Board meetings

12 Aug 2026 Board Meeting - Financial Results